Is it still suitable to depend on AstraZeneca for COVID-19 vaccine donations to developing countries?
Curr Med Res Opin
.
2022 Dec;38(12):2127-2130.
doi: 10.1080/03007995.2022.2129233.
Epub 2022 Oct 13.
Authors
Abdelrahman M Makram
1
2
3
,
Van Phu Tran
3
4
,
Randa Elsheikh
2
3
,
Nguyen Thi Hien Hau
3
5
6
,
Siti Mariam Abd Gani
3
7
,
Nguyen Tien Huy
7
Affiliations
1
School of Public Health, Imperial College London, London, UK.
2
Faculty of Medicine, October 6 University, Giza, Egypt.
3
Online Research Club, Nagasaki, Japan.
4
Department of Medicine, Tra Vinh University, Tra Vinh City, Vietnam.
5
Faculty of Medicine, College of Medicine and Pharmacy, Duy Tan University, Da Nang City, Vietnam.
6
Institute for Research and Training in Medicine, Biology and Pharmacy, Duy Tan University, Da Nang City, Vietnam.
7
School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
PMID:
36164756
DOI:
10.1080/03007995.2022.2129233
No abstract available
Publication types
Editorial
MeSH terms
COVID-19 Vaccines* / therapeutic use
COVID-19* / prevention & control
Developing Countries
Humans
Substances
COVID-19 Vaccines